141 related articles for article (PubMed ID: 20686473)
1. Dacryoadenitis, an extra-intestinal manifestation of Crohn's disease.
Wong JC; Rossman D; Bressler B
Am J Gastroenterol; 2010 Aug; 105(8):1904-6. PubMed ID: 20686473
[No Abstract] [Full Text] [Related]
2. Methotrexate: the best choice for second-line maintenance treatment in active Crohn's disease?
Grimaldi C
Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):21-2. PubMed ID: 18977624
[No Abstract] [Full Text] [Related]
3. [Biological therapy as treatment of inflammatory bowel diseases].
Agnholt J
Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
Barthel HR; Gille T; Halbsguth A; Kramer M
J Gastroenterol Hepatol; 2005 Sep; 20(9):1464-5. PubMed ID: 16105142
[No Abstract] [Full Text] [Related]
5. A case of fistulizing Crohn's disease and erythema nodosum managed with adalimumab.
Quin A; Kane S; Ulitsky O
Nat Clin Pract Gastroenterol Hepatol; 2008 May; 5(5):278-81. PubMed ID: 18364718
[TBL] [Abstract][Full Text] [Related]
6. [The use of adalimumab in severe fistulising Crohn's disease].
Bang UC; Nielsen AM
Ugeskr Laeger; 2008 Jun; 170(25):2256. PubMed ID: 18565318
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Crohn's disease presenting as genital warts: successful treatment with adalimumab.
Lestre S; Ramos J; João A; Serrão V
Eur J Dermatol; 2010; 20(4):504-5. PubMed ID: 20507839
[No Abstract] [Full Text] [Related]
8. Metastatic vulval Crohn's disease and infliximab: a case report.
Tritton SM; Whyte L; Fischer G
J Reprod Med; 2009 Jan; 54(1):41-4. PubMed ID: 19263879
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous metastatic Crohn's disease responsive to infliximab.
Petrolati A; Altavilla N; Cipolla R; Fenderico P; Forlini G; Nasoni S; Rossi Z
Am J Gastroenterol; 2009 Apr; 104(4):1058. PubMed ID: 19259072
[No Abstract] [Full Text] [Related]
10. Duodenal Crohn's disease successfully treated with adalimumab.
Tursi A
Endoscopy; 2011; 43 Suppl 2 UCTN():E22. PubMed ID: 21271523
[No Abstract] [Full Text] [Related]
11. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
[TBL] [Abstract][Full Text] [Related]
12. Treatment of vulval Crohn's disease with infliximab.
Preston PW; Hudson N; Lewis FM
Clin Exp Dermatol; 2006 May; 31(3):378-80. PubMed ID: 16681581
[TBL] [Abstract][Full Text] [Related]
13. [Metastatic Crohn's disease].
Romero Gutiérrez M; Alcántara Torres M; Muñoz Rosas C; Gómez Moreno AZ; Guardiola Arévalo A; Rodríguez Merlo R; Carrobles Jiménez JM
Gastroenterol Hepatol; 2010; 33(6):440-4. PubMed ID: 20537428
[TBL] [Abstract][Full Text] [Related]
14. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
Laharie D; Reffet A; Belleannée G; Chabrun E; Subtil C; Razaire S; Capdepont M; de Lédinghen V
Aliment Pharmacol Ther; 2011 Mar; 33(6):714-21. PubMed ID: 21235604
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for multidrug therapy in active Crohn's disease?
Forbes A
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S257-8. PubMed ID: 18816649
[No Abstract] [Full Text] [Related]
16. A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease.
Koilakou S; Karapiperis D; Tzathas C
Am J Gastroenterol; 2010 Jan; 105(1):231-2. PubMed ID: 20054324
[No Abstract] [Full Text] [Related]
17. [Treatment of Crohn's disease: step-up or top-down?].
Herrlinger K; Stange EF
Dtsch Med Wochenschr; 2010 Aug; 135(34-35):1694-8. PubMed ID: 20721847
[No Abstract] [Full Text] [Related]
18. Orofacial granulomatosis as first manifestation of Crohn's disease: successful treatment of both conditions with a combination of infliximab and dapsone.
Kemmler N; Pfannschmidt N; Strohal R
Acta Derm Venereol; 2012 Jul; 92(4):406-7. PubMed ID: 22113308
[No Abstract] [Full Text] [Related]
19. [Recommendations for patients with Crohn's disease starting treatment with adalimumab: a rapid guide].
Cabriada JL; García Sánchez V; Gomollón F; Hinojosa J; López San Román A; Mendoza JL; Mínguez M; Ricart E; Saro C
Gastroenterol Hepatol; 2008 Dec; 31(10):693-7. PubMed ID: 19174086
[No Abstract] [Full Text] [Related]
20. Development of the nephrotic syndrome during treatment of Crohn's disease with adalimumab.
Gupta A; Pendyala P; Arora P; Sitrin MD
J Clin Gastroenterol; 2011 Mar; 45(3):e30-3. PubMed ID: 20975576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
